# Edoardo Mannucci

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/edoardo-mannucci/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,079 |
| Field | Diabetes Treatment and Management |
| h-index | 101 |
| i10-index | 439 |
| Last Known Institution | Azienda Ospedaliero-Universitaria Careggi |
| OpenAlex ID | https://openalex.org/A5059685674 |
| ORCID iD | 0000-0001-9759-9408 |
| Works | 766 |

## Researcher papers

Showing 12 of 18.

- [Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study](https://scholariq.org/papers/hypogonadism-as-a-risk-factor-for-cardiovascular-mortality-in-men-a-meta/)
- [Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis](https://scholariq.org/papers/body-weight-loss-reverts-obesity-associated-hypogonadotropic-hypogonadism-a/)
- [Testosterone and Metabolic Syndrome: A Meta-Analysis Study](https://scholariq.org/papers/testosterone-and-metabolic-syndrome-a-meta-analysis-study/)
- [Type 2 diabetes mellitus and testosterone: a meta-analysis study](https://scholariq.org/papers/type-2-diabetes-mellitus-and-testosterone-a-meta-analysis-study/)
- [Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trials](https://scholariq.org/papers/effect-of-metformin-on-cardiovascular-events-and-mortality-a-meta-analysis-of/)
- [Depression as a Risk Factor for Diabetes](https://scholariq.org/papers/depression-as-a-risk-factor-for-diabetes/)
- [Diagnostic Crossover and Outcome Predictors in Eating Disorders According to DSM-IV and DSM-V Proposed Criteria: A 6-Year Follow-Up Study](https://scholariq.org/papers/diagnostic-crossover-and-outcome-predictors-in-eating-disorders-according-to-dsm/)
- [Effect of Metformin on Glucagon-Like Peptide 1 (GLP-1) and Leptin Levels in Obese Nondiabetic Subjects](https://scholariq.org/papers/effect-of-metformin-on-glucagon-like-peptide-1-glp-1-and-leptin-levels-in-obese/)
- [Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis](https://scholariq.org/papers/cardiovascular-risk-associated-with-testosterone-boosting-medications-a/)
- [Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial](https://scholariq.org/papers/efficacy-and-safety-of-dapagliflozin-in-patients-with-inadequately-controlled/)
- [Efficacy and safety of sodium glucose co‐transport‐2 inhibitors in type 2 diabetes: a meta‐analysis of randomized clinical trials](https://scholariq.org/papers/efficacy-and-safety-of-sodium-glucose-co-transport-2-inhibitors-in-type-2/)
- [Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures](https://scholariq.org/papers/dipeptidyl-peptidase-4-inhibitors-and-bone-fractures/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Hormonal and reproductive studies](https://scholariq.org/topics/hormonal-and-reproductive-studies/)
- [Sexual function and dysfunction studies](https://scholariq.org/topics/sexual-function-and-dysfunction-studies/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

## Researcher university

- [Azienda Ospedaliero-Universitaria Careggi](https://scholariq.org/institutions/azienda-ospedaliero-universitaria-careggi/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.